
FCPM III SERVICES B.V.
Latest 13F filing data - Q4 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | ENGN | 9.63M | $86.98M |
![]() | NAMS | 9.20M | $322.70M |
![]() | DYN | 5.46M | $106.85M |
![]() | VOR | 3.62M | $47.31M |
![]() | BCYC | 3.47M | $24.56M |
![]() | MPLT | 3.23M | $56.67M |
![]() | REPL | 2.81M | $27.30M |
![]() | RAPT | 1.83M | $62.09M |
![]() | CBIO | 1.68M | $19.90M |

enGene Holdings Inc.
ENGN
Shares Held
9.63M
Value
$86.98M

NewAmsterdam Pharma Company N.V.
NAMS
Shares Held
9.20M
Value
$322.70M

Dyne Therapeutics, Inc.
DYN
Shares Held
5.46M
Value
$106.85M

Vor Biopharma Inc.
VOR
Shares Held
3.62M
Value
$47.31M

Bicycle Therapeutics plc
BCYC
Shares Held
3.47M
Value
$24.56M

MapLight Therapeutics, Inc.
MPLT
Shares Held
3.23M
Value
$56.67M

Replimune Group, Inc.
REPL
Shares Held
2.81M
Value
$27.30M

RAPT Therapeutics, Inc.
RAPT
Shares Held
1.83M
Value
$62.09M

Crescent Biopharma, Inc.
CBIO
Shares Held
1.68M
Value
$19.90M
